HEALTHCARE INVESTMENTS

PHARMACEUTICALS & BIOTECHNOLOGY
ARKIN BIO 

Arkin Bio identifies, invests in, and accompanies innovative early and mid-stage companies with game-changing breakthroughs in areas such as: immunotherapy, cancer, metabolism, microbiome, CNS, autoimmune diseases, orphan diseases and drug delivery platforms.

The experienced Arkin Bio ’ management team, leads and supports its portfolio companies through the hurdles of drug development, towards the proof of concept stage and beyond, to significant value creation.

Arkin Bio is currently invested in companies in various stages of product development.